The ENDIS already confirmed a positive effect of adjuvant therapy with SGLT-2 inhibitors and GLP-1 analogs on endothelial function in T1DM patients based on various functional tests [22]. Here, SLC5A2 is linked to type 1 diabetes mellitus.